Abstract
Lung cancer remains the most common cause of cancer-related deaths in the USA and worldwide. An estimated 220,000 new cases are diagnosed, while nearly 160,000 patients die from lung cancer each year in the USA alone, accounting for more cancer-related deaths than the next three most common cancers combined: colon, breast, and prostate [Jemal A et al., CA Cancer J Clin 61:69–9, 2011; Siegel R et al., CA Cancer J Clin 61:212–6, 2011]. In spite of major advances achieved in lung cancer diagnosis, medical, surgical treatment, and palliative care, the overall 5-year survival for lung cancer has not noticeably changed over the past 20 years and is estimated around 16 % [Goldstraw P et al., J Thorac Oncol 2:706–14, 2007]. These dismal statistics compare poorly with those of other common cancers such as colon, breast, and prostate cancers characterized by 5-year survival rates of 65 %, 88 % and 99 %, respectively. Among the many potential explanations advanced to explain such differences, the lack of effective screening for lung cancer is often contrasted to what are generally assumed and accepted screening strategies for those other malignancies. Lung cancer is in the majority of cases diagnosed at advanced stages, as symptoms prompt patients to seek medical attention, when curative therapeutic options are at best limited.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212–36.
Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007;2:706–14.
Cole P, Morrison AS. Basic issues in population screening for cancer. J Natl Cancer Inst. 1980;64:1263–72.
Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.
Fontana RS, Sanderson DR, Taylor WF, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis. 1984;130:561–5.
Frost JK, Ball Jr WC, Levin ML, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis. 1984;130:549–54.
Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, Martini N. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest. 1984;86:44–53.
Marcus PM, Bergstralh EJ, Fagerstrom RM, et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst. 2000;92:1308–16.
Ebeling K, Nischan P. Screening for lung cancer–results from a case–control study. Int J Cancer. 1987;40:141–4.
Nishii K, Ueoka H, Kiura K, et al. A case–control study of lung cancer screening in Okayama Prefecture, Japan. Lung Cancer. 2001;34:325–32.
Okamoto N, Suzuki T, Hasegawa H, et al. Evaluation of a clinic-based screening program for lung cancer with a case–control design in Kanagawa, Japan. Lung Cancer. 1999;25:77–85.
Sagawa M, Tsubono Y, Saito Y, et al. A case–control study for evaluating the efficacy of mass screening program for lung cancer in Miyagi Prefecture, Japan. Cancer. 2001;92:588–94.
Tsukada H, Kurita Y, Yokoyama A, et al. An evaluation of screening for lung cancer in Niigata Prefecture, Japan: a population-based case–control study. Br J Cancer. 2001;85:1326–31.
Oken MM, Marcus PM, Hu P, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 2011;306(17):1865–73.
Baker SG, Kramer BS, Prorok PC. Statistical issues in randomized trials of cancer screening. BMC Med Res Methodol. 2002;2:11.
Yau G, Lock M, Rodrigues G. Systematic review of baseline low-dose CT lung cancer screening. Lung Cancer. 2007;58:161–70.
Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355:1763–71.
Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. JAMA. 2007;297:953–61.
McMahon PM, Kong CY, Johnson BE, et al. Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology. 2008;248:278–87.
Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 2010;363:1203–10.
Ost DE, Gould MK. Decision making in the patient with pulmonary nodules. Am J Respir Crit Care Med. 2012;185(4):363–72.
Lindell RM, Hartman TE, Swensen SJ, et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology. 2007;242:555–62.
Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology. 2005;235:259–65.
Detterbeck FC, Gibson CJ. Turning gray: the natural history of lung cancer over time. J Thorac Oncol. 2008;3:781–92.
Bach PB. Is our natural-history model of lung cancer wrong? Lancet Oncol. 2008;9:693–7.
Bach PB. Lung cancer screening. J Natl Compr Canc Netw. 2008;6:271–5.
Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:244–85.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Maldonado, F., Edell, E.S. (2013). Lung Cancer Screening and the National Lung Screening Trial (NLST). In: Díaz-Jimenez, J., Rodriguez, A. (eds) Interventions in Pulmonary Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6009-1_17
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6009-1_17
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6008-4
Online ISBN: 978-1-4614-6009-1
eBook Packages: MedicineMedicine (R0)